SCYNEXIS, Inc. (SCYX) vs Zhengye Biotechnology Holding Limited (ZYBT)
- SCYNEXIS, Inc. SCYX 3.67 −6.14%
- Zhengye Biotechnology Holding Limited ZYBT 1.43 −4.67%
SCYNEXIS, Inc. and Zhengye Biotechnology Holding Limited are both Drug Manufacturers Specialty & Generic companies. Zhengye Biotechnology Holding Limited is the larger, with a market value of $44.6M against $38.9M — 1.1× the size. Across the 9 metrics below, Zhengye Biotechnology Holding Limited leads on 6 and SCYNEXIS, Inc. on 3.
Valuation
Profitability
| Metric | SCYX | ZYBT | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | — | 53.94% |
| Operating margin | (109.90%) | — | 0.00% |
| Net margin | (49.74%) | — | 0.00% |
| Free cash flow margin | (64.67%) | 0.00% | 0.00% |
| Return on equity | (18.38%) | 0.00% | (0.40%) |
| Return on assets | (15.09%) | 0.00% | (3.32%) |
| Return on invested capital | (110.72%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack